Stock listing
Insight Molecular Diagnostics Inc.
- Ticker
- NASDAQ:IMDX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Insight Molecular Diagnostics Inc.
The company focuses on developing innovative diagnostic solutions in the molecular diagnostics field. Its commitment to advancing healthcare through precise and efficient testing positions it as a key player in the industry.
Latest news from Insight Molecular Diagnostics Inc.
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
Sep 2, 2026
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
Aug 10, 2026
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
Aug 4, 2026
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
Jul 23, 2026